SKYCOVIONE Trademark

Trademark Overview


On Tuesday, November 23, 2021, a trademark application was filed for SKYCOVIONE with the United States Patent and Trademark Office. The USPTO has given the SKYCOVIONE trademark a serial number of 79329154. The federal status of this trademark filing is REGISTERED as of Tuesday, June 27, 2023. This trademark is owned by SK bioscience Co., Ltd.. The SKYCOVIONE trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, for the treatment of respiratory infectious diseases and disorders; Veterinary preparations for the treatment of respiratory diseases and disorders; Drugs for medical purposes, namely, for treating viral infections and respiratory diseases and disorders; Pharmaceuticals for human purposes, namely, for treating viral infections and respiratory diseases and disorders; vaccines; veterinary vaccines; viral vaccines; human vaccine preparations; vaccines against pneumococcal infections; Medical diagnostic reagents for medical use, namely for detecting immunization disease; diagnostic agents for pharmaceutical use; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; antiviral agents; immunotherapeutic agents for bacterial infections; bacterial preparations for medical purposes; reagents for use in diagnostic tests for medical purposes; sterilizing washes; disinfectants for chemical...
skycovione

General Information


Serial Number79329154
Word MarkSKYCOVIONE
Filing DateTuesday, November 23, 2021
Status700 - REGISTERED
Status DateTuesday, June 27, 2023
Registration Number7088836
Registration DateTuesday, June 27, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Goods and ServicesMedicines for human purposes, namely, for the treatment of respiratory infectious diseases and disorders; Veterinary preparations for the treatment of respiratory diseases and disorders; Drugs for medical purposes, namely, for treating viral infections and respiratory diseases and disorders; Pharmaceuticals for human purposes, namely, for treating viral infections and respiratory diseases and disorders; vaccines; veterinary vaccines; viral vaccines; human vaccine preparations; vaccines against pneumococcal infections; Medical diagnostic reagents for medical use, namely for detecting immunization disease; diagnostic agents for pharmaceutical use; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; antiviral agents; immunotherapeutic agents for bacterial infections; bacterial preparations for medical purposes; reagents for use in diagnostic tests for medical purposes; sterilizing washes; disinfectants for chemical toilets; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, and nasal secretion analysis
Pseudo MarkSKY COVIONE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSK bioscience Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameSK bioscience Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSK bioscience Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Saturday, March 16, 2024LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, October 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 29, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 29, 2023FINAL DISPOSITION PROCESSED
Wednesday, September 27, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 27, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 27, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, June 11, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 24, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 24, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, May 22, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, February 8, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 24, 2023NOTIFICATION PROCESSED BY IB
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 21, 2022ATTORNEY REVIEW COMPLETED
Tuesday, July 19, 2022LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Wednesday, June 22, 2022REFUSAL PROCESSED BY IB
Saturday, May 28, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, May 28, 2022REFUSAL PROCESSED BY MPU
Tuesday, April 26, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, April 25, 2022NON-FINAL ACTION WRITTEN
Tuesday, April 19, 2022ASSIGNED TO EXAMINER
Saturday, February 12, 2022LIMITATION OF GOODS RECEIVED FROM IB
Saturday, January 8, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, January 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 23, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB